5,449 adverse vaccine reactions ↑… 9 deaths, including those in their 30s, causality unconfirmed (total)

As the number of people vaccinated against the novel coronavirus infection (COVID-19) in Korea increases, the number of reports of adverse reactions has increased by 5,400 over the past three days.

The quarantine authorities plan to confirm the relevance to vaccination through expert evaluation in the future for suspected cases of death or serious adverse reactions.

◇ 83 cases of suspected adverse reactions after cross-vaccination… 4 major adverse reactions

According to the COVID-19 Vaccination Response Promotion Team on the 7th, a total of 5,449 new cases were reported to the health authorities, saying that an adverse reaction was suspected after vaccination on the 4th to 6th.

By vaccine type, 3,772 from Pfizer, 1,388 from Moderna, 261 from AstraZeneca (AZ), and 28 from Janssen.

Daily adverse reaction reports were 1,747 on the 4th, 1,837 on the 5th, and 1,865 on the 6th.

Nine new deaths were reported.

Most of the deaths were elderly people over the age of 60. By age, there are 3 people in their 70s, 2 each in their 80s and 50s, and 1 each in their 60s and 30s.

By gender, there were 7 males and 2 females. The deceased, a female childcare teacher in her 30s, who was vaccinated at a consignment medical care and inoculation center, had no underlying disease during her lifetime, and four of the dead had underlying diseases.

The time from vaccination to death varied from 1 to about 44 days, some of which are still under investigation.

Seven of the deaths were reported to have received Pfizer, one AstraZeneca, and one Moderna vaccine. The promotion team will evaluate whether it is related to vaccination through expert evaluation.

The number of suspected cases of ‘anaphylaxis’, a severe systemic allergic reaction, increased by 17. Fifteen were from Pfizer and two from Moderna vaccinated.

There were 134 major adverse events (Pfizer 99, AstraZeneca 23, Moderna 11, Janssen 1), including adverse reaction cases of ‘special interest’, intensive care unit hospitalization, life-threatening, permanent disability and sequelae.

The remaining cases reported redness, pain, swelling, muscle pain, and headache at the injection site, which are common after vaccination.

After the first dose of AstraZeneca vaccine, the second dose of the Pfizer vaccine, the number of suspected adverse reactions related to the cross-vaccination increased by 83, to a cumulative total of 2,819.

There were no deaths among 83 new cases, but there were 1 case of suspected anaphylaxis and 4 cases of major adverse reactions.

Cross-vaccination adverse reactions are counted as duplicates in the total adverse reaction report.

◇ Adverse reactions, at the level of 0.46% of the cumulative number of inoculations… Total death toll is 639

A cumulative total of 127,14 cases of suspected adverse reactions reported since February 26, when vaccination was started in Korea.

This is 0.46% compared to the cumulative number of inoculations (27,339,87) as of 00:00 that day.

So far, the reporting rate of adverse reactions relative to the number of vaccinations by vaccine has been 0.67% each for AstraZeneca and Janssen, 0.47% for Moderna, and 0.27% for Pfizer.

Authorities are classifying adverse reaction cases based on the first symptoms at the time of notification.

As of 00:00 on that day, a total of 448 deaths were reported.

By vaccine type, Pfizer had 258 cases, AstraZeneca 182 cases, Janssen 7 cases, and Moderna 1 case.

If 191 people died (191 people) who were reported first due to other symptoms, but their condition worsened and died, the total number of deaths was 639. By vaccine, 372 from Pfizer, 257 from AstraZeneca, 9 from Janssen, and 1 from Moderna.

The total number of suspected anaphylaxis cases is 567 (AstraZeneca 274 cases, Pfizer 233 cases, Janssen 45 cases, Moderna 15 cases).

A total of 5,65 cases of suspected major adverse reactions (AstraZeneca 3108 cases, Pfizer 1,637 cases, Janssen 275 cases, Moderna 45 cases).

12934 cases, which account for 95.2% of all adverse reaction reports (127,14 cases), were general cases classified as relatively mild symptoms such as muscle pain, headache, fever, and nausea after vaccination.

The quarantine authorities publish statistics on reports of adverse reactions after vaccination three times a week on Mondays, Wednesdays, and Saturdays.

[연합뉴스]

Copyrights ⓒ Yonhap News. Unauthorized reproduction and redistribution prohibited